[Pseudomonas aeruginosa infections].
D000667:Ampicillin / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000382:microbiology; D004751:Enteritis / Q000209:etiology; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D006814:Hungary; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000382:microbiology*; D007235:Infant, Premature, Diseases / Q000382:microbiology*; D007612:Kanamycin / Q000627:therapeutic use; D007709:Klebsiella / Q000302:isolation & purification; D007710:Klebsiella Infections / Q000150:complications / Q000188:drug therapy; D008297:Male; D008581:Meningitis / Q000209:etiology; D008712:Methicillin / Q000627:therapeutic use; D011014:Pneumonia / Q000209:etiology; D011113:Polymyxins / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification / Q000472:pathogenicity*; D018805:Sepsis / Q000209:etiology; D012877:Skin Manifestations
D005839:Gentamicins; D011113:Polymyxins; D007612:Kanamycin; D000667:Ampicillin; D008712:Methicillin
Pseudomonas aeruginosa-Infektionen.